BB-R12

N/A

Report date: 2025/01/26 16:29:26

Base Information

Drug NameBB-R12

Drug Alias Nameadeno-associated viral 6 vector based ribonuclease reductase gene therapy (BEAT)AAV6-based ribonuclease reductase gene therapy (BEAT BioTherapeutics)BB-R12

ClassificationBiologics

Mechanisms of ActionRibonucleotide reductase gene transference

TargetsRibonucleotide reductase

Therapy Area/IndicationsHeart Failure

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesBEAT BioTherapeutics Corp

China Registration ClassN/A

Develop Information

Active CompaniesBEAT BioTherapeutics Corp

Inactive CompaniesN/A

Active IndicationsHeart Failure

Inactive IndicationsN/A

Other Information

ATC CodeN/A